Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Functional ketchup?

This article was originally published in The Tan Sheet

Executive Summary

Heinz agreement to introduce DHA-, ARA-fortified infant formula in Australia, New Zealand gives Martek Biosciences an opportunity for future forays into functional foods market. H.J. Heinz subsidiary Heinz Wattie's Limited announces non-exclusive license agreement May 1 for use of Martek's DHA, ARA nutritional oil technology; the deal provides for initial cash payments and gives Martek an ongoing royalty once Heinz introduces fortified formula. Separately, Martek completes acquisition of OmegaTech April 25; DHA producer now is a wholly owned subsidiary of Martek and has become Martek Biosciences Boulder Corp. (1"The Tan Sheet" April 1, 2002, p. 3)...

You may also be interested in...



Martek Expands Access To DHA Food, Beverage Market With OmegaTech Buy

Martek Biosciences is looking to gain greater access to the nascent DHA-fortified food and beverage market with the acquisition of Boulder, Colo.-based OmegaTech

Sales Already Growing As Vascepa Secures Cardio Approval

Company forecasts 2020 sales as high as $700m after regulator grants broad label.

Another EU MDR Notified Body In The Netherlands

Last week, the Commission  revealed that three more notified bodies had been designated; but their listings had not been made official. Now we learn that one of the three is in the Netherlands as the first listing takes place.

Topics

UsernamePublicRestriction

Register

PS093999

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel